4//SEC Filing
YAROSHEVSKY GLANVILLE MARY 4
Accession 0001209191-04-058556
CIK 0001128495other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 8:49 PM ET
Size
6.0 KB
Accession
0001209191-04-058556
Insider Transaction Report
Form 4
YAROSHEVSKY GLANVILLE MARY
Senior Director, Human Capital
Transactions
- Award
Stock Option (Right to Buy)
2004-12-15+30,000→ 30,000 totalExercise: $7.00From: 2005-12-15Exp: 2014-12-14→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest and become exercisable one year from the date of the grant with the remaining shares subject to the option vesting in equal monthly installments evenly over the next three year period such that all shares subject to the option will be fully vested and exercisable as of December 15, 2008.
Documents
Issuer
ANADYS PHARMACEUTICALS INC
CIK 0001128495
Entity typeother
Related Parties
1- filerCIK 0001283305
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 8:49 PM ET
- Size
- 6.0 KB